Cystic Fibrosis Treatment Market, Global Outlook and Forecast 2022-2028

March 2022 | 110 pages | ID: C51759FEF8CCEN
Market Monitor Global

Abstracts

Cystic fibrosis (CF) is a hereditary disease characterized by abnormalities in the body's salt, aquatic cells, and mucus-producing cells.

This report contains market size and forecasts of Cystic Fibrosis Treatment in Global, including the following market information:

Global Cystic Fibrosis Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Cystic Fibrosis Treatment market was valued at 6895.8 million in 2021 and is projected to reach US$ 13630 million by 2028, at a CAGR of 10.2% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Oral Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Cystic Fibrosis Treatment include Actavis, F. Hoffmann-La Roche, Gilead Sciences, Novartis, Vertex Pharmaceuticals, Abbott, Anthera Pharmaceuticals, Arcturus Therapeutics and Boehringer Ingelheim, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cystic Fibrosis Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Cystic Fibrosis Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Cystic Fibrosis Treatment Market Segment Percentages, by Type, 2021 (%)

• Oral
• Injection

Global Cystic Fibrosis Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Cystic Fibrosis Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics
• Other

Global Cystic Fibrosis Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Cystic Fibrosis Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Cystic Fibrosis Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Cystic Fibrosis Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Actavis
• F. Hoffmann-La Roche
• Gilead Sciences
• Novartis
• Vertex Pharmaceuticals
• Abbott
• Anthera Pharmaceuticals
• Arcturus Therapeutics
• Boehringer Ingelheim
• Chiesi Farmaceutici
• Corbus Pharmaceuticals
• Genzyme
• Insmed
• Johnson & Johnson
• Merck Sharp & Dohme
• Neovii Biotech
• Novo Nordisk
• PharmaSwiss
• Pharmaxis
• Proteostasis Therapeutics
• PTC Therapeutics
• United Medical
• Venus Remedies

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Cystic Fibrosis Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Cystic Fibrosis Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CYSTIC FIBROSIS TREATMENT OVERALL MARKET SIZE

2.1 Global Cystic Fibrosis Treatment Market Size: 2021 VS 2028
2.2 Global Cystic Fibrosis Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Cystic Fibrosis Treatment Players in Global Market
3.2 Top Global Cystic Fibrosis Treatment Companies Ranked by Revenue
3.3 Global Cystic Fibrosis Treatment Revenue by Companies
3.4 Top 3 and Top 5 Cystic Fibrosis Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Cystic Fibrosis Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cystic Fibrosis Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Cystic Fibrosis Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Cystic Fibrosis Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Cystic Fibrosis Treatment Market Size Markets, 2021 & 2028
  4.1.2 Oral
  4.1.3 Injection
4.2 By Type - Global Cystic Fibrosis Treatment Revenue & Forecasts
  4.2.1 By Type - Global Cystic Fibrosis Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Cystic Fibrosis Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Cystic Fibrosis Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Cystic Fibrosis Treatment Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Clinics
  5.1.4 Other
5.2 By Application - Global Cystic Fibrosis Treatment Revenue & Forecasts
  5.2.1 By Application - Global Cystic Fibrosis Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Cystic Fibrosis Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Cystic Fibrosis Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Cystic Fibrosis Treatment Market Size, 2021 & 2028
6.2 By Region - Global Cystic Fibrosis Treatment Revenue & Forecasts
  6.2.1 By Region - Global Cystic Fibrosis Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Cystic Fibrosis Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Cystic Fibrosis Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Cystic Fibrosis Treatment Revenue, 2017-2028
  6.3.2 US Cystic Fibrosis Treatment Market Size, 2017-2028
  6.3.3 Canada Cystic Fibrosis Treatment Market Size, 2017-2028
  6.3.4 Mexico Cystic Fibrosis Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Cystic Fibrosis Treatment Revenue, 2017-2028
  6.4.2 Germany Cystic Fibrosis Treatment Market Size, 2017-2028
  6.4.3 France Cystic Fibrosis Treatment Market Size, 2017-2028
  6.4.4 U.K. Cystic Fibrosis Treatment Market Size, 2017-2028
  6.4.5 Italy Cystic Fibrosis Treatment Market Size, 2017-2028
  6.4.6 Russia Cystic Fibrosis Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Cystic Fibrosis Treatment Market Size, 2017-2028
  6.4.8 Benelux Cystic Fibrosis Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Cystic Fibrosis Treatment Revenue, 2017-2028
  6.5.2 China Cystic Fibrosis Treatment Market Size, 2017-2028
  6.5.3 Japan Cystic Fibrosis Treatment Market Size, 2017-2028
  6.5.4 South Korea Cystic Fibrosis Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Cystic Fibrosis Treatment Market Size, 2017-2028
  6.5.6 India Cystic Fibrosis Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Cystic Fibrosis Treatment Revenue, 2017-2028
  6.6.2 Brazil Cystic Fibrosis Treatment Market Size, 2017-2028
  6.6.3 Argentina Cystic Fibrosis Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Cystic Fibrosis Treatment Revenue, 2017-2028
  6.7.2 Turkey Cystic Fibrosis Treatment Market Size, 2017-2028
  6.7.3 Israel Cystic Fibrosis Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Cystic Fibrosis Treatment Market Size, 2017-2028
  6.7.5 UAE Cystic Fibrosis Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Actavis
  7.1.1 Actavis Corporate Summary
  7.1.2 Actavis Business Overview
  7.1.3 Actavis Cystic Fibrosis Treatment Major Product Offerings
  7.1.4 Actavis Cystic Fibrosis Treatment Revenue in Global Market (2017-2022)
  7.1.5 Actavis Key News
7.2 F. Hoffmann-La Roche
  7.2.1 F. Hoffmann-La Roche Corporate Summary
  7.2.2 F. Hoffmann-La Roche Business Overview
  7.2.3 F. Hoffmann-La Roche Cystic Fibrosis Treatment Major Product Offerings
  7.2.4 F. Hoffmann-La Roche Cystic Fibrosis Treatment Revenue in Global Market (2017-2022)
  7.2.5 F. Hoffmann-La Roche Key News
7.3 Gilead Sciences
  7.3.1 Gilead Sciences Corporate Summary
  7.3.2 Gilead Sciences Business Overview
  7.3.3 Gilead Sciences Cystic Fibrosis Treatment Major Product Offerings
  7.3.4 Gilead Sciences Cystic Fibrosis Treatment Revenue in Global Market (2017-2022)
  7.3.5 Gilead Sciences Key News
7.4 Novartis
  7.4.1 Novartis Corporate Summary
  7.4.2 Novartis Business Overview
  7.4.3 Novartis Cystic Fibrosis Treatment Major Product Offerings
  7.4.4 Novartis Cystic Fibrosis Treatment Revenue in Global Market (2017-2022)
  7.4.5 Novartis Key News
7.5 Vertex Pharmaceuticals
  7.5.1 Vertex Pharmaceuticals Corporate Summary
  7.5.2 Vertex Pharmaceuticals Business Overview
  7.5.3 Vertex Pharmaceuticals Cystic Fibrosis Treatment Major Product Offerings
  7.5.4 Vertex Pharmaceuticals Cystic Fibrosis Treatment Revenue in Global Market (2017-2022)
  7.5.5 Vertex Pharmaceuticals Key News
7.6 Abbott
  7.6.1 Abbott Corporate Summary
  7.6.2 Abbott Business Overview
  7.6.3 Abbott Cystic Fibrosis Treatment Major Product Offerings
  7.6.4 Abbott Cystic Fibrosis Treatment Revenue in Global Market (2017-2022)
  7.6.5 Abbott Key News
7.7 Anthera Pharmaceuticals
  7.7.1 Anthera Pharmaceuticals Corporate Summary
  7.7.2 Anthera Pharmaceuticals Business Overview
  7.7.3 Anthera Pharmaceuticals Cystic Fibrosis Treatment Major Product Offerings
  7.7.4 Anthera Pharmaceuticals Cystic Fibrosis Treatment Revenue in Global Market (2017-2022)
  7.7.5 Anthera Pharmaceuticals Key News
7.8 Arcturus Therapeutics
  7.8.1 Arcturus Therapeutics Corporate Summary
  7.8.2 Arcturus Therapeutics Business Overview
  7.8.3 Arcturus Therapeutics Cystic Fibrosis Treatment Major Product Offerings
  7.8.4 Arcturus Therapeutics Cystic Fibrosis Treatment Revenue in Global Market (2017-2022)
  7.8.5 Arcturus Therapeutics Key News
7.9 Boehringer Ingelheim
  7.9.1 Boehringer Ingelheim Corporate Summary
  7.9.2 Boehringer Ingelheim Business Overview
  7.9.3 Boehringer Ingelheim Cystic Fibrosis Treatment Major Product Offerings
  7.9.4 Boehringer Ingelheim Cystic Fibrosis Treatment Revenue in Global Market (2017-2022)
  7.9.5 Boehringer Ingelheim Key News
7.10 Chiesi Farmaceutici
  7.10.1 Chiesi Farmaceutici Corporate Summary
  7.10.2 Chiesi Farmaceutici Business Overview
  7.10.3 Chiesi Farmaceutici Cystic Fibrosis Treatment Major Product Offerings
  7.10.4 Chiesi Farmaceutici Cystic Fibrosis Treatment Revenue in Global Market (2017-2022)
  7.10.5 Chiesi Farmaceutici Key News
7.11 Corbus Pharmaceuticals
  7.11.1 Corbus Pharmaceuticals Corporate Summary
  7.11.2 Corbus Pharmaceuticals Business Overview
  7.11.3 Corbus Pharmaceuticals Cystic Fibrosis Treatment Major Product Offerings
  7.11.4 Corbus Pharmaceuticals Cystic Fibrosis Treatment Revenue in Global Market (2017-2022)
  7.11.5 Corbus Pharmaceuticals Key News
7.12 Genzyme
  7.12.1 Genzyme Corporate Summary
  7.12.2 Genzyme Business Overview
  7.12.3 Genzyme Cystic Fibrosis Treatment Major Product Offerings
  7.12.4 Genzyme Cystic Fibrosis Treatment Revenue in Global Market (2017-2022)
  7.12.5 Genzyme Key News
7.13 Insmed
  7.13.1 Insmed Corporate Summary
  7.13.2 Insmed Business Overview
  7.13.3 Insmed Cystic Fibrosis Treatment Major Product Offerings
  7.13.4 Insmed Cystic Fibrosis Treatment Revenue in Global Market (2017-2022)
  7.13.5 Insmed Key News
7.14 Johnson & Johnson
  7.14.1 Johnson & Johnson Corporate Summary
  7.14.2 Johnson & Johnson Business Overview
  7.14.3 Johnson & Johnson Cystic Fibrosis Treatment Major Product Offerings
  7.14.4 Johnson & Johnson Cystic Fibrosis Treatment Revenue in Global Market (2017-2022)
  7.14.5 Johnson & Johnson Key News
7.15 Merck Sharp & Dohme
  7.15.1 Merck Sharp & Dohme Corporate Summary
  7.15.2 Merck Sharp & Dohme Business Overview
  7.15.3 Merck Sharp & Dohme Cystic Fibrosis Treatment Major Product Offerings
  7.15.4 Merck Sharp & Dohme Cystic Fibrosis Treatment Revenue in Global Market (2017-2022)
  7.15.5 Merck Sharp & Dohme Key News
7.16 Neovii Biotech
  7.16.1 Neovii Biotech Corporate Summary
  7.16.2 Neovii Biotech Business Overview
  7.16.3 Neovii Biotech Cystic Fibrosis Treatment Major Product Offerings
  7.16.4 Neovii Biotech Cystic Fibrosis Treatment Revenue in Global Market (2017-2022)
  7.16.5 Neovii Biotech Key News
7.17 Novo Nordisk
  7.17.1 Novo Nordisk Corporate Summary
  7.17.2 Novo Nordisk Business Overview
  7.17.3 Novo Nordisk Cystic Fibrosis Treatment Major Product Offerings
  7.17.4 Novo Nordisk Cystic Fibrosis Treatment Revenue in Global Market (2017-2022)
  7.17.5 Novo Nordisk Key News
7.18 PharmaSwiss
  7.18.1 PharmaSwiss Corporate Summary
  7.18.2 PharmaSwiss Business Overview
  7.18.3 PharmaSwiss Cystic Fibrosis Treatment Major Product Offerings
  7.18.4 PharmaSwiss Cystic Fibrosis Treatment Revenue in Global Market (2017-2022)
  7.18.5 PharmaSwiss Key News
7.19 Pharmaxis
  7.19.1 Pharmaxis Corporate Summary
  7.19.2 Pharmaxis Business Overview
  7.19.3 Pharmaxis Cystic Fibrosis Treatment Major Product Offerings
  7.19.4 Pharmaxis Cystic Fibrosis Treatment Revenue in Global Market (2017-2022)
  7.19.5 Pharmaxis Key News
7.20 Proteostasis Therapeutics
  7.20.1 Proteostasis Therapeutics Corporate Summary
  7.20.2 Proteostasis Therapeutics Business Overview
  7.20.3 Proteostasis Therapeutics Cystic Fibrosis Treatment Major Product Offerings
  7.20.4 Proteostasis Therapeutics Cystic Fibrosis Treatment Revenue in Global Market (2017-2022)
  7.20.5 Proteostasis Therapeutics Key News
7.21 PTC Therapeutics
  7.21.1 PTC Therapeutics Corporate Summary
  7.21.2 PTC Therapeutics Business Overview
  7.21.3 PTC Therapeutics Cystic Fibrosis Treatment Major Product Offerings
  7.21.4 PTC Therapeutics Cystic Fibrosis Treatment Revenue in Global Market (2017-2022)
  7.21.5 PTC Therapeutics Key News
7.22 United Medical
  7.22.1 United Medical Corporate Summary
  7.22.2 United Medical Business Overview
  7.22.3 United Medical Cystic Fibrosis Treatment Major Product Offerings
  7.22.4 United Medical Cystic Fibrosis Treatment Revenue in Global Market (2017-2022)
  7.22.5 United Medical Key News
7.23 Venus Remedies
  7.23.1 Venus Remedies Corporate Summary
  7.23.2 Venus Remedies Business Overview
  7.23.3 Venus Remedies Cystic Fibrosis Treatment Major Product Offerings
  7.23.4 Venus Remedies Cystic Fibrosis Treatment Revenue in Global Market (2017-2022)
  7.23.5 Venus Remedies Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Cystic Fibrosis Treatment Market Opportunities & Trends in Global Market
Table 2. Cystic Fibrosis Treatment Market Drivers in Global Market
Table 3. Cystic Fibrosis Treatment Market Restraints in Global Market
Table 4. Key Players of Cystic Fibrosis Treatment in Global Market
Table 5. Top Cystic Fibrosis Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Cystic Fibrosis Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Cystic Fibrosis Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Cystic Fibrosis Treatment Product Type
Table 9. List of Global Tier 1 Cystic Fibrosis Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cystic Fibrosis Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Cystic Fibrosis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Cystic Fibrosis Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Cystic Fibrosis Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Cystic Fibrosis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Cystic Fibrosis Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Cystic Fibrosis Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Cystic Fibrosis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Cystic Fibrosis Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Cystic Fibrosis Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Cystic Fibrosis Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Cystic Fibrosis Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Cystic Fibrosis Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Cystic Fibrosis Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Cystic Fibrosis Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Cystic Fibrosis Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Cystic Fibrosis Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Cystic Fibrosis Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Cystic Fibrosis Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Cystic Fibrosis Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Actavis Corporate Summary
Table 31. Actavis Cystic Fibrosis Treatment Product Offerings
Table 32. Actavis Cystic Fibrosis Treatment Revenue (US$, Mn), (2017-2022)
Table 33. F. Hoffmann-La Roche Corporate Summary
Table 34. F. Hoffmann-La Roche Cystic Fibrosis Treatment Product Offerings
Table 35. F. Hoffmann-La Roche Cystic Fibrosis Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Gilead Sciences Corporate Summary
Table 37. Gilead Sciences Cystic Fibrosis Treatment Product Offerings
Table 38. Gilead Sciences Cystic Fibrosis Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Novartis Corporate Summary
Table 40. Novartis Cystic Fibrosis Treatment Product Offerings
Table 41. Novartis Cystic Fibrosis Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Vertex Pharmaceuticals Corporate Summary
Table 43. Vertex Pharmaceuticals Cystic Fibrosis Treatment Product Offerings
Table 44. Vertex Pharmaceuticals Cystic Fibrosis Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Abbott Corporate Summary
Table 46. Abbott Cystic Fibrosis Treatment Product Offerings
Table 47. Abbott Cystic Fibrosis Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Anthera Pharmaceuticals Corporate Summary
Table 49. Anthera Pharmaceuticals Cystic Fibrosis Treatment Product Offerings
Table 50. Anthera Pharmaceuticals Cystic Fibrosis Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Arcturus Therapeutics Corporate Summary
Table 52. Arcturus Therapeutics Cystic Fibrosis Treatment Product Offerings
Table 53. Arcturus Therapeutics Cystic Fibrosis Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Boehringer Ingelheim Corporate Summary
Table 55. Boehringer Ingelheim Cystic Fibrosis Treatment Product Offerings
Table 56. Boehringer Ingelheim Cystic Fibrosis Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Chiesi Farmaceutici Corporate Summary
Table 58. Chiesi Farmaceutici Cystic Fibrosis Treatment Product Offerings
Table 59. Chiesi Farmaceutici Cystic Fibrosis Treatment Revenue (US$, Mn), (2017-2022)
Table 60. Corbus Pharmaceuticals Corporate Summary
Table 61. Corbus Pharmaceuticals Cystic Fibrosis Treatment Product Offerings
Table 62. Corbus Pharmaceuticals Cystic Fibrosis Treatment Revenue (US$, Mn), (2017-2022)
Table 63. Genzyme Corporate Summary
Table 64. Genzyme Cystic Fibrosis Treatment Product Offerings
Table 65. Genzyme Cystic Fibrosis Treatment Revenue (US$, Mn), (2017-2022)
Table 66. Insmed Corporate Summary
Table 67. Insmed Cystic Fibrosis Treatment Product Offerings
Table 68. Insmed Cystic Fibrosis Treatment Revenue (US$, Mn), (2017-2022)
Table 69. Johnson & Johnson Corporate Summary
Table 70. Johnson & Johnson Cystic Fibrosis Treatment Product Offerings
Table 71. Johnson & Johnson Cystic Fibrosis Treatment Revenue (US$, Mn), (2017-2022)
Table 72. Merck Sharp & Dohme Corporate Summary
Table 73. Merck Sharp & Dohme Cystic Fibrosis Treatment Product Offerings
Table 74. Merck Sharp & Dohme Cystic Fibrosis Treatment Revenue (US$, Mn), (2017-2022)
Table 75. Neovii Biotech Corporate Summary
Table 76. Neovii Biotech Cystic Fibrosis Treatment Product Offerings
Table 77. Neovii Biotech Cystic Fibrosis Treatment Revenue (US$, Mn), (2017-2022)
Table 78. Novo Nordisk Corporate Summary
Table 79. Novo Nordisk Cystic Fibrosis Treatment Product Offerings
Table 80. Novo Nordisk Cystic Fibrosis Treatment Revenue (US$, Mn), (2017-2022)
Table 81. PharmaSwiss Corporate Summary
Table 82. PharmaSwiss Cystic Fibrosis Treatment Product Offerings
Table 83. PharmaSwiss Cystic Fibrosis Treatment Revenue (US$, Mn), (2017-2022)
Table 84. Pharmaxis Corporate Summary
Table 85. Pharmaxis Cystic Fibrosis Treatment Product Offerings
Table 86. Pharmaxis Cystic Fibrosis Treatment Revenue (US$, Mn), (2017-2022)
Table 87. Proteostasis Therapeutics Corporate Summary
Table 88. Proteostasis Therapeutics Cystic Fibrosis Treatment Product Offerings
Table 89. Proteostasis Therapeutics Cystic Fibrosis Treatment Revenue (US$, Mn), (2017-2022)
Table 90. PTC Therapeutics Corporate Summary
Table 91. PTC Therapeutics Cystic Fibrosis Treatment Product Offerings
Table 92. PTC Therapeutics Cystic Fibrosis Treatment Revenue (US$, Mn), (2017-2022)
Table 93. United Medical Corporate Summary
Table 94. United Medical Cystic Fibrosis Treatment Product Offerings
Table 95. United Medical Cystic Fibrosis Treatment Revenue (US$, Mn), (2017-2022)
Table 96. Venus Remedies Corporate Summary
Table 97. Venus Remedies Cystic Fibrosis Treatment Product Offerings
Table 98. Venus Remedies Cystic Fibrosis Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Cystic Fibrosis Treatment Segment by Type in 2021
Figure 2. Cystic Fibrosis Treatment Segment by Application in 2021
Figure 3. Global Cystic Fibrosis Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Cystic Fibrosis Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Cystic Fibrosis Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cystic Fibrosis Treatment Revenue in 2021
Figure 8. By Type - Global Cystic Fibrosis Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Cystic Fibrosis Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Cystic Fibrosis Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Cystic Fibrosis Treatment Revenue Market Share, 2017-2028
Figure 12. US Cystic Fibrosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Cystic Fibrosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Cystic Fibrosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Cystic Fibrosis Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Cystic Fibrosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Cystic Fibrosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Cystic Fibrosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Cystic Fibrosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Cystic Fibrosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Cystic Fibrosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Cystic Fibrosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Cystic Fibrosis Treatment Revenue Market Share, 2017-2028
Figure 24. China Cystic Fibrosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Cystic Fibrosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Cystic Fibrosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Cystic Fibrosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Cystic Fibrosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Cystic Fibrosis Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Cystic Fibrosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Cystic Fibrosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Cystic Fibrosis Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Cystic Fibrosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Cystic Fibrosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Cystic Fibrosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Cystic Fibrosis Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Actavis Cystic Fibrosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. F. Hoffmann-La Roche Cystic Fibrosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Gilead Sciences Cystic Fibrosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Novartis Cystic Fibrosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Vertex Pharmaceuticals Cystic Fibrosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Abbott Cystic Fibrosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Anthera Pharmaceuticals Cystic Fibrosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Arcturus Therapeutics Cystic Fibrosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Boehringer Ingelheim Cystic Fibrosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Chiesi Farmaceutici Cystic Fibrosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Corbus Pharmaceuticals Cystic Fibrosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Genzyme Cystic Fibrosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Insmed Cystic Fibrosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Johnson & Johnson Cystic Fibrosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Merck Sharp & Dohme Cystic Fibrosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Neovii Biotech Cystic Fibrosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Novo Nordisk Cystic Fibrosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. PharmaSwiss Cystic Fibrosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. Pharmaxis Cystic Fibrosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 56. Proteostasis Therapeutics Cystic Fibrosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 57. PTC Therapeutics Cystic Fibrosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 58. United Medical Cystic Fibrosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 59. Venus Remedies Cystic Fibrosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)